Table 2.

Side-to-side comparison of subtypes of liposarcoma, by database.

		Sample Size	Median Age	% Female	Median Survival (IQR) in Years	5-Year Survival	10-Year Survival
Well-Differentiated	SEERc	4298	63	40.6	15.8 (7.4–26.3)	0.823	0.669
	ICESb	548	57	39.6	NAa (22.1 - NAa)	0.904	0.809
Myxoid	SEER	3241	50	41.5	17.8 (5.5-NAa)	0.764	0.636
	ICES	319	47	39.8	NAa (NAa - NAa)	0.882	0.787
Round Cell	SEER	304	50	44.7	7.5 (1.7–25.3)	0.549	0.467
	ICES	60	45	43.3	18.5 (13.1 - NAa)	0.854	0.676
Pleomorphic	SEER	1203	66	40.6	5.3 (1.7–16.2)	0.512	0.348
	ICES	132	63	40.9	4.4 (3.1–6.8)	0.477	0.352
Mixed	SEER	453	56	38.4	9.7 (2.3–23.2)	0.628	0.498
	ICES	22	55	50.0	6.4 (2.7 - NAa)	0.707	0.530
Fibroblastic	SEER	17	36	64.7	NAa	0.941	0.753
	ICES	3	42	66.7	NAa (NAa - NAa)	1.000	NAa
De-Differentiated	SEER	2164	66	33.1	4.9 (1.6–14.0)	0.494	0.321
	ICES	182	67	37.4	11.4 (7.3 - NAa)	0.754	0.672

^cSurveillance, Epidemiology, and End Results Program Database.

^bCanadian Institute for Clinical Evaluative Sciences.

^aNot applicable due to insufficient sample size or failure of mortality to fall below 0.500.